Ra Capital Management, L.P.

13F Holdings History for ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

Symbol: ITOS
Investment type: Equity / Common stock, par value $0.001 per share
Latest Disclosed Ownership: 2.13M shares
Security Ownership: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in ITeos Therapeutics, Inc. Common stock, par value $0.001 per share (ITOS)

2025-05-19 - RA Capital Management, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.13M shares of ITeos Therapeutics, Inc. Common stock, par value $0.001 per share (ITOS). This represents 4.9% percent ownership of the company. In their previous filing dated 2025-05-14, RA CAPITAL MANAGEMENT, L.P. had reported owning 4.16M shares, indicating a decrease of -48.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
RA Capital Management, L.P.	4.9%	-50%	$15.7M	2.13M	-2,028,470	-48.7%	$7.35	13D/A	5/15/2025	19 May 2025 17:46:06
RA Capital Management, L.P.	9.9%		$23.5M	4.16M			$5.65	13D/A	5/12/2025	14 May 2025 18:34:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025		-0.36%	$0	0	-3,649,057	-100%		Q2 2025
3/31/2025	0.36%	+0.16%	$21.8M	3.65M	+1,556,798		$5.97	Q1 2025
12/31/2024	0.21%	-0.11%	$16.1M	2.09M	-1,092,452	-34.3%	$7.68	Q4 2024
9/30/2024	0.37%	-0.04%	$32.5M	3.18M	-332,548	-9.45%	$10.21	Q3 2024
6/30/2024	0.69%	-0.17%	$52.2M	3.52M	-900,000	-20.4%	$14.84	Q2 2024
3/31/2024	0.78%		$60.3M	4.42M			$13.64	Q1 2024
12/31/2023	0.76%		$48.4M	4.42M			$10.95	Q4 2023
9/30/2023	0.95%		$48.4M	4.42M			$10.95	Q3 2023
6/30/2023	1.1%		$58.5M	4.42M			$13.24	Q2 2023
3/31/2023	1.36%		$60.1M	4.42M			$13.61	Q1 2023
12/31/2022	1.75%		$86.3M	4.42M			$19.53	Q4 2022
9/30/2022	1.8%		$84.1M	4.42M			$19.05	Q3 2022
6/30/2022	2.43%		$91M	4.42M			$20.60	Q2 2022
3/31/2022	3.1%		$142M	4.42M			$32.18	Q1 2022
12/31/2021	3.63%		$206M	4.42M			$46.56	Q4 2021
9/30/2021	1.65%		$119M	4.42M			$27.00	Q3 2021
6/30/2021	1.82%		$113M	4.42M	+1	+0%	$25.65	Q2 2021
3/31/2021	2.28%		$151M	4.42M			$34.18	Q1 2021
12/31/2020	2.09%		$149M	4.42M			$33.82	Q4 2020
9/30/2020	1.99%	+1.99%	$109M	4.42M	+4,417,258	NEW	$24.67	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.